Exploration of key clinical trial data and real-world evidence on dupilumab in asthma and COPD presented at the ERS and CHEST ...

India has the second-highest incidence of chronic obstructive pulmonary disease (CoPD) in the world, after China. What you need to know about CoPD and the cost of treatment for the chronic lung ...

GSK’s Nucala receives positive CHMP opinion for treatment of chronic obstructive pulmonary disease: London, UK Monday, December 15, 2025, 16:00 Hrs [IST] GSK plc announced that ...

GlaxoSmithKline ( ($GB:GSK) ) has issued an update. GSK has announced that the European Medicines Agency’s Committee for Medicinal Products for ...

Experts call for urgent action to turn around an "unacceptable" decline in testing for a disease that kills 20 people every ...

GSK gets CHMP backing for Nucala in COPD and depemokimab in asthma, setting up possible Europe approvals in 2026 for IL-5 therapies.

China plans to intensify its battle against chronic diseases such as cancer and respiratory illnesses over the next five ...

Among seven new medicines recommended for approval by the EMA's human medicine advisory committee at its latest meeting is ...

London: GSK has announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency ...

A new survey reveals 82% of Delhi-NCR residents know someone suffering serious health issues attributed to long-term air ...

Non-cystic fibrosis bronchiectasis (NCFB) is a heterogeneous disease characterised by a ‘vicious vortex’ of ...

GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines ...